資源描述：
《益腎平肝湯干預(yù)治療高血壓早期腎損害蛋白尿臨床地研究》由會員上傳分享，免費在線閱讀，更多相關(guān)內(nèi)容在學術(shù)論文-天天文庫。
1、ClinicalObservationofyishenpinggancompound'sTreatmentofearlyrenalinjureofessentialhypertensionandmicroalbuminuriaSpecialty：MedicalDepartmentofTCMAuthor：HuangHaiyanTutor：Prof.GaoJiandongAbstractPurpose：Thisstudymonitorsthechangesofthesymptomsandindexesthata
2、rerelatedtotheessentialhypertensionpatientswithearlyrenalinjurebeforeandaftertreatment,toobserveyishenpinggancompound'seffectofinterventionandtreatmenttoearlyrenalinjureofessentialhypertension.Methods：Togather60patientsthatareessentialhypertensionpatientsw
3、ithearlyrenalinjure,allthecasesareoutpatientandinpatientthatcomefromthesecondaffiliatedhospitalofShandongUniversityofTraditionalChineseMedicineinDecember2010toDecember2011.Atotalof60patientswererandomlydividedintoexperimentalgroupandcontrolgroup,eachgrouph
4、ave30cases.Bothgroupswererequestedtobelow-saltdiet,quitsmokingandwine,attendtoappropriatephysicalexercise,etc;combinedhyperlipidemiaandhyperuricaemiatotreatintime.Accordingtothedisease,allpatientsweregivenfelodipinetablets5~10mg/d,onthebasisofantihypertens
5、ivetherapy,ifnecessary,plusmetoprololtablets25~50mg/d.TheexperimentalgroupweregivenyishenpinggancompoundwhilethecontrolgroupweretreatedwithOkracapsules.Courseoftreatmentwere2months.Thelaboratoryparameters,suchasurinarymicroalbumin,urineosmolality,serumcrea
6、tinine(Scr),bloodureanitrogen(BUN),β2-microglobulin,lipidsandsoon,wereobservedbeforeandaftertreatment.Atthetime,wemustobservethechangesof24hambulatorybloodpressure,Clinicalsymptoms,tongueandpluse.Results：Aftertwomonthstreatment,thetotalefficiencyoftheexper
7、imentalgroupis93.3%,thatofthecontrolgroupis66.7%.BytheWilcoxonranksumtest,Z=-2.547,P=0.011,P<0.05，thedifferencewereprominent.Theexperimentalgrouparesignificantlybetterthanthecontrolgroupinimprovingtheclinicalsymptomsofdizziness,headache,backache,nocturia,f
8、iveupsethot,choroidbloodstasis,tongueandpluse,reducingurinaryalbuminandbloodpressure,increasingurineosmolality（P<0.01or0.05）.Conclusion：Yishenpinggancompoundwasprovedtobeeffectivetoimprovetheclinicalsymptoman
